About CCBC
China Cord Blood Corporation (NYSE: CO) is a life sciences enterprise dedicated to the storage of umbilical cord blood stem cells, leveraging the rapid developments in life sciences research and the increasing popularity and rapid advancement of clinical applications using stem cells.
About CCBC
China Cord Blood Corporation (NYSE: CO) is a life sciences enterprise dedicated to the storage of umbilical cord blood stem cells, leveraging the rapid developments in life sciences research and the increasing popularity and rapid advancement of clinical applications using stem cells.
About CCBC
China Cord Blood Corporation (NYSE: CO) is a life sciences enterprise dedicated to the storage of umbilical cord blood stem cells, leveraging the rapid developments in life sciences research and the increasing popularity and rapid advancement of clinical applications using stem cells.
Latest News
Dec
10
China Cord Blood Corporation Announces Results of 2015 Annual General Meeting
Nov
24
China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2016
Nov
16
China Cord Blood Corporation to Report Second Quarter and First Half of Fiscal 2016 Financial Results
Oct
30
China Cord Blood Corporation Guangdong Subsidiary Has Been Accredited by American Association of Blood Banks
Sep
23
China Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 10, 2015
Aug
26
China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017
Aug
20
China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2016
Aug
13
China Cord Blood Corporation to Report First Quarter of Fiscal 2016 Financial Results
Aug
6
China Cord Blood Corporation Announces Receipt of Non-Binding Acquisition Proposal
Jul
31
China Cord Blood Corporation Files Its Annual Report on Form 20-F
Jun
19
China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2015
Jun
9
China Cord Blood Corporation to Report Fourth Quarter and Full Year of Fiscal 2015 Financial Results
Jun
2
China Cord Blood Corporation's Special Committee Appoints Independent Financial Advisor and Legal Counsel to Evaluate Non-binding "Going Private" Proposal
May
14
China Cord Blood Corporation Announces Resignation of an Independent Director
May
8
China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017 Held by Cordlife and Magnum and its Ordinary Shares Held by Cordlife